1. Home
  2. OCUL vs PDX Comparison

OCUL vs PDX Comparison

Compare OCUL & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • PDX
  • Stock Information
  • Founded
  • OCUL 2006
  • PDX 2019
  • Country
  • OCUL United States
  • PDX NY
  • Employees
  • OCUL N/A
  • PDX N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • PDX Finance/Investors Services
  • Sector
  • OCUL Health Care
  • PDX Finance
  • Exchange
  • OCUL Nasdaq
  • PDX Nasdaq
  • Market Cap
  • OCUL 957.3M
  • PDX 1.1B
  • IPO Year
  • OCUL 2014
  • PDX N/A
  • Fundamental
  • Price
  • OCUL $7.45
  • PDX $22.15
  • Analyst Decision
  • OCUL Strong Buy
  • PDX
  • Analyst Count
  • OCUL 10
  • PDX 0
  • Target Price
  • OCUL $16.11
  • PDX N/A
  • AVG Volume (30 Days)
  • OCUL 1.6M
  • PDX N/A
  • Earning Date
  • OCUL 05-05-2025
  • PDX 01-01-0001
  • Dividend Yield
  • OCUL N/A
  • PDX 4.95%
  • EPS Growth
  • OCUL N/A
  • PDX N/A
  • EPS
  • OCUL N/A
  • PDX N/A
  • Revenue
  • OCUL $59,647,000.00
  • PDX N/A
  • Revenue This Year
  • OCUL $13.32
  • PDX N/A
  • Revenue Next Year
  • OCUL $13.13
  • PDX N/A
  • P/E Ratio
  • OCUL N/A
  • PDX N/A
  • Revenue Growth
  • OCUL N/A
  • PDX N/A
  • 52 Week Low
  • OCUL $4.06
  • PDX $13.52
  • 52 Week High
  • OCUL $11.78
  • PDX $21.05
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 48.17
  • PDX 50.77
  • Support Level
  • OCUL $8.07
  • PDX $21.85
  • Resistance Level
  • OCUL $8.90
  • PDX $22.85
  • Average True Range (ATR)
  • OCUL 0.48
  • PDX 0.54
  • MACD
  • OCUL -0.08
  • PDX 0.21
  • Stochastic Oscillator
  • OCUL 29.68
  • PDX 67.74

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest

PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.

Share on Social Networks: